Latest

John Oliver
Health

From rural Kentucky to HBO: The story of the Sackler deposition hits pop culture big-time

By Andrew Joseph

Pharmalot

Judge slams Justice Department bid to dismiss a nurse educator lawsuit

By Ed Silverman

Xarelto
Pharmalot

A first-of-its-kind law in Tennessee limits lawyers’ ads seeking to sue drug makers

By Ed Silverman

FDA Securities Fraud
Health

FDA halts sales of pelvic mesh tied to injuries in women

By Associated Press

Pharmalot

Pharmalittle: Look who’s advising Nancy Pelosi on drug prices; Purdue tried to buy an opioid-addiction treatment business

By Ed Silverman

Daphne Koller
Biotech

In a test for AI, a buzzy machine learning startup inks drug discovery deal with Gilead

By Matthew Herper and Rebecca Robbins

STAT SPOTLIGHT
Biotech

Startup Spotlight: Flagship reveals Kintai Therapeutics — yet another microbiome company

By Kate Sheridan

Measles Outbreak Exemptions
Morning Rounds

A jump in measles cases & debating ‘three-parent IVF’

By Shraddha Chakradhar

The READOUT
The Readout

The state of the NASH race & a (relatively) new idea in Alzheimer’s

By Damian Garde

Yellow Fever vaccine
First Opinion

Life-course vaccination can protect adults from infectious disease

By Lois Privor-Dumm

Mice, the problem with
First Opinion

The trouble with mice as behavioral models for Alzheimer’s and other neurologic diseases

By Adam Rosenberg

Liver illustration
Biotech

The NASH race: A fleeting frontrunner, a stumbling giant, and others in biotech look to the finish line

By Adam Feuerstein

Mitochondrial painting
Health

Patient advocates and scientists launch push to lift ban on ‘three-parent IVF’

By Emily Mullin

STAT PLUS - Janet Woodcock
Pharmalot

FDA’s Woodcock on developing neuromuscular drugs: ‘We have to change our approach’

By Ed Silverman

Blurry doctors
Pharmalot

A database that reveals industry payments to doctors also causes patient mistrust

By Ed Silverman

Pile of mice
In the Lab

It’s just in mice! This scientist is calling out hype in science reporting

By Shraddha Chakradhar

Nancy Pelosi, Wendell Primus
Politics

The health policy experts shaping Nancy Pelosi’s approach to drug pricing

By Lev Facher

Pharmalot

Supreme Court rejects Allergan bid to use a Native American tribe to shield important patents

By Ed Silverman

Pharmalot

Pharmalittle: J&J gets U.S. nod for first targeted bladder cancer drug; Allergan wins key support from advisory firms

By Ed Silverman

The READOUT
The Readout

Bickering Democrats & data from Alnylam

By Meghana Keshavan

FDA Added Sugar Label
Morning Rounds

Tax services in hospitals & health savings from added sugar labeling

By Shraddha Chakradhar

Dr. Peter Bach
Business

Peter Bach’s latest crazy idea: Give up on biosimilars. Regulate drug prices instead

By Matthew Herper and Ed Silverman

HIV life cycle
First Opinion

He Jiankui, embryo editing, CCR5, the London patient, and jumping to conclusions

By Henry T. Greely

Nancy Pelosi & Lloyd Doggett
Politics

Democrats feud over drug pricing policy, as progressives push pragmatists to be bolder

By Lev Facher and Nicholas Florko

Biotech

Latest Alnylam data underscores positive results for new RNAi drug candidate, at least for some patients

By Kate Sheridan

Ebola vaccine
Health

The data are clear: Ebola vaccine shows ‘very impressive’ performance in outbreak

By Helen Branswell

Ebola screening point
Health

WHO stops short of declaring Ebola crisis a global health emergency

By Helen Branswell

JUST MERGERED
Pharma

The Bristol-Celgene merger is approved. Here are 8 challenges ahead

By Damian Garde and Adam Feuerstein

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy